Outcomes and Treatment Approaches for Stage III Inflammatory versus Noninflammatory Breast Cancer - Scorecard - MDSpire

Outcomes and Treatment Approaches for Stage III Inflammatory versus Noninflammatory Breast Cancer

  • By

  • José P. Leone

  • Julieta Leone

  • Pietro De Placido

  • Faina Nakhlis

  • Ilana Schlam

  • Kelly A. Hirko

  • Aditi Hazra

  • Elizabeth Troll

  • Jennifer R. Bellon

  • Carlos T. Vallejo

  • Nancy U. Lin

  • Sara M. Tolaney

  • Filipa Lynce

  • April 9, 2026

  • 0 min

Share

Clinical Scorecard: Outcomes and Treatment Approaches for Stage III Inflammatory versus Noninflammatory Breast Cancer

At a Glance

CategoryDetail
Condition
Key MechanismsIBC is characterized by rapid onset of symptoms such as erythema and/or edema involving at least one-third of the breast, and is considered rare and aggressive.
Target Population
Care Setting

Key Highlights

  • Treatment de-escalation has not been shown to be safe for IBC, unlike in non-IBC cases, where it may be appropriate.

Guideline-Based Recommendations

Diagnosis

  • IBC is identified by T4d primary tumors; non-IBC includes other stage III tumors, specifically those not classified as T4d.

Management

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Patients with IBC are more likely to be non-Hispanic White, single, and have lower median income, which may impact treatment outcomes.

        Clinical Best Practices

        • Adhere to trimodality therapy for IBC patients and monitor both breast cancer-specific survival (BCSS) and overall survival (OS) closely.

        References

        Original Source(s)

        Outcomes and Treatment Approaches for Stage III Inflammatory versus Noninflammatory Breast Cancer

        • by José P. Leone, Julieta Leone, Pietro De Placido, Faina Nakhlis, Ilana Schlam, Kelly A. Hirko, Aditi Hazra, Elizabeth Troll, Jennifer R. Bellon, Carlos T. Vallejo, Nancy U. Lin, Sara M. Tolaney, Filipa Lynce

        • April 9, 2026

        Related Content

        Management of toxicities from antibody – drug conjugates in breast cancer

        Peripheral blood monocytes could be associated with brain metastasis and affect patient prognosis in breast cancer: a retrospective study

        Combined reconstruction of complex chest wall defects using mesh-supported rigid materials and abdominal flap strategies: a retrospective clinical study